Treatment of hypertriglyceridemia with tibric acid and clofibrate — Cross-over studies, effects on lipoproteins and absence of post-drug rebound
- 1 March 1978
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 29 (3) , 345-354
- https://doi.org/10.1016/0021-9150(78)90081-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemia in type IV and type V hyperlipoproteinaemiasAtherosclerosis, 1977
- Effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemiaMetabolism, 1977
- Clofibrate-induced low density lipoprotein elevation therapeutic implications and treatment by colestipol resinAtherosclerosis, 1976
- Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese MenNew England Journal of Medicine, 1976
- Differences among Hyperlipoproteinaemic Subjects in the Response of Lipoprotein Lipids to Resin TherapyEuropean Journal of Clinical Investigation, 1975
- Dose‐response to tibric acid: A new hypolipidemic drug in type IV hyperlipoproteinemiaClinical Pharmacology & Therapeutics, 1975
- Metabolic relationships among the plasma lipoproteinsJournal of Clinical Investigation, 1972
- ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROLThe Lancet, 1972
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971